334 related articles for article (PubMed ID: 30450104)
1. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
3. [Clinical study on cytomegalovirus infection after hematopoietic stem cell transplantation in 26 patients with primary immunodeficiency diseases].
Que M; Xiao J; Guan X; Xian Y; Su Y; Wen X; Li Y; Wang Y; Xiao L; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):424-7. PubMed ID: 24857213
[TBL] [Abstract][Full Text] [Related]
4. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
5. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP.
Lanzi G; Moratto D; Vairo D; Masneri S; Delmonte O; Paganini T; Parolini S; Tabellini G; Mazza C; Savoldi G; Montin D; Martino S; Tovo P; Pessach IM; Massaad MJ; Ramesh N; Porta F; Plebani A; Notarangelo LD; Geha RS; Giliani S
J Exp Med; 2012 Jan; 209(1):29-34. PubMed ID: 22231303
[TBL] [Abstract][Full Text] [Related]
6. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation in primary immunodeficiency disease patients.
Sato T; Kobayashi R; Toita N; Kaneda M; Hatano N; Iguchi A; Kawamura N; Ariga T
Pediatr Int; 2007 Dec; 49(6):795-800. PubMed ID: 18045274
[TBL] [Abstract][Full Text] [Related]
8. Advances in hematopoietic stem cell transplantation for primary immunodeficiency.
Gennery AR; Cant AJ
Immunol Allergy Clin North Am; 2008 May; 28(2):439-56, x-xi. PubMed ID: 18424341
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
10. WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.
Ramesh N; Antón IM; Hartwig JH; Geha RS
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14671-6. PubMed ID: 9405671
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.
Boztug H; Karitnig-Weiß C; Ausserer B; Renner ED; Albert MH; Sawalle-Belohradsky J; Belohradsky BH; Mann G; Horcher E; Rümmele-Waibel A; Geyeregger R; Lakatos K; Peters C; Lawitschka A; Matthes-Martin S
Pediatr Hematol Oncol; 2012 Oct; 29(7):585-94. PubMed ID: 22897717
[TBL] [Abstract][Full Text] [Related]
12. WASP-WIP complex in the molecular pathogenesis of Wiskott-Aldrich syndrome.
Sasahara Y
Pediatr Int; 2016 Jan; 58(1):4-7. PubMed ID: 26331277
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team.
Tsuji Y; Imai K; Kajiwara M; Aoki Y; Isoda T; Tomizawa D; Imai M; Ito S; Maeda H; Minegishi Y; Ohkawa H; Yata J; Sasaki N; Kogawa K; Nagasawa M; Morio T; Nonoyama S; Mizutani S
Bone Marrow Transplant; 2006 Mar; 37(5):469-77. PubMed ID: 16435016
[TBL] [Abstract][Full Text] [Related]
14. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation corrects WIP deficiency.
Al-Mousa H; Hawwari A; Al-Ghonaium A; Al-Saud B; Al-Dhekri H; Al-Muhsen S; Elshorbagi S; Dasouki M; El-Baik L; Alseraihy A; Ayas M; Arnaout R
J Allergy Clin Immunol; 2017 Mar; 139(3):1039-1040.e4. PubMed ID: 27742395
[No Abstract] [Full Text] [Related]
16. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
17. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein.
Stewart DM; Tian L; Nelson DL
J Immunol; 1999 Apr; 162(8):5019-24. PubMed ID: 10202051
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.
Slatter MA; Gennery AR
Expert Rev Clin Immunol; 2018 Feb; 14(2):103-114. PubMed ID: 29300535
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions.
Dvorak CC; Gilman AL; Horn B; Jaroscak J; Dunn EA; Baxter-Lowe LA; Cowan MJ
Bone Marrow Transplant; 2009 Dec; 44(12):805-12. PubMed ID: 19421175
[TBL] [Abstract][Full Text] [Related]
20. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
